SlideShare a Scribd company logo
1 of 4
Download to read offline
1 | P a g e
InitiatingCoverage
tiatingCoverage
tingCoverage
gCoverage
Coverage
verage
rage
ge
PI Industries Ltd.
Q1FY15ResultUpdate–30July2014
4
Recommendation HOLD Another strong performance…
PI Industries posted strong quarter with 16% growth in sales for the quarter.
However, key highlight of the quarter is improvement in margins which has
moved up by ~348 up yoy and ~859 bps qoq (Q1 is seasonally strong quarter in
terms of margins) to 22.9%. The company is expected to end FY15 with sales
growth of 20% with 100-200 bps improvement in margins (as against the earlier
guidance of 25% growth and stable margins).
Key Highlights
 CSM: Key highlight of the quarter was increase in order book to $435mn
from $395 mn in Q4FY14 despite clocking revenues of Rs 225 cr (up 8%
yoy). Q3 and Q4 quarters are expected to high growth quarters as the
company is expecting few products to get commercialized in addition with
higher volumes from existing products. Top 5 products contribute 45% of
revenues and Top 5 customers’ accounts for 50-60% of revenues. Jambusar
plant is working at its full capacity hence the company is undergoing Phase
II expansion and putting up two new lines at the site which are expected to
be operational by Q2FY16 with capex of Rs 300 cr spread over FY15-16.
Management has guided for 20% growth for FY15.
 Agri: PI industries’ Agri segment has reported healthy sales growth of
24.5% at Rs 246cr for the quarter. The performance is backed equally by
both volume growth (12-13%) and mix of price and product mix (12-13%).
One in-licensed insecticide to be launched in Q2FY15 and one more
product in Rabi season. despite posting good growth in Q1, the company
has lowered its guidance to 20% as a cautious move owning to current
monsoon season.
Valuation & Recommendation
We believe that healthy order book of CSM, strong balance sheet and new
product launches in Agri Input segment will drive near to medium term growth.
On the other hand CSM segment gaining traction with higher margins is acting
as a de-risk model to domestic business. In addition, macro factors like low per-
capita pesticides consumption in the country, increasing MSPs and increasing
acceptance for the need of crop protection products make PI Industries a good
long term bet. We continue to maintain our positive stance on the stock. We
recommend to HOLD the stock for the price target of Rs 465 (20x on FY16E
EPS)
CMP (28/07/14) Rs 406
Target Price Rs 465
Sector Agrochemicals
Stock Details
BSE Code 523642
NSE Code PIIND
Bloomberg Code PI IN
Market Cap (Rs cr) 5,526
Free Float (%) 41.4
52- wk HI/Lo (Rs) 434/120
Avg. volume BSE (Quarterly) 26,076
Face Value (Rs) Re. 1
Dividend (FY 14) 200%
Shares o/s (Cr) 13.55
Relative Performance 1Mth 3Mth 1Yr
PI Ind. 21.7% 65.6% 208.8%
Sensex 2.7% 14.6% 31.6%
Shareholding Pattern 30
th
June 14
Promoters Holding 58.57
Institutional (Incl. FII) 25.11
Corporate Bodies 2.44
Public & others 13.88
Runjhun Jain 022 3926 8177
Senior Research Analyst
runjhun.jain@nirmalbang.com
Year
Consolidated
Sales
(Rs cr)
Growth
(%)
EBITDA
(Rs cr)
Margin
(%)
Rep. PAT
(Rs cr)
Margin
(%)
EPS
(Rs)
P/E
(x)
ROE
(%)
FY13A 1151.4 31.0% 180.9 15.7% 97.3 8.5% 7.2 56.8 22.7%
FY14A 1595.5 38.6% 289.0 18.1% 188.1 11.8% 13.8 29.4 30.7%
FY15E 1963.8 23.1% 379.0 19.3% 246.5 12.6% 18.1 22.4 30.9%
FY16E 2414.3 22.9% 475.6 19.7% 316.4 13.1% 23.2 17.5 30.6%
0
100
200
300
400
500
25-Jul 25-Oct 25-Jan 25-Apr 25-Jul
2 | P a g e
InitiatingCoverage
tiatingCoverage
tingCoverage
gCoverage
Coverage
verage
rage
ge
PI Industries Ltd.
Q1FY15ResultUpdate–30July2014
Quarterly Result Table (Standalone)
Particulars (Rs Cr) Q1FY15 Q1FY14 yoy Q4FY14 qoq
Net Sales 471.2 406.1 16.0% 362.7 29.9%
Cost of materials 247.3 221.8 11.5% 191.9 28.9%
Purchase of goods 20.8 18.2 14.4% 5.8 259.7%
Employees Cost 31.7 27.4 15.8% 31.8 -0.4%
Other Exps 63.5 59.8 6.1% 81.3 -21.9%
EBITDA 108.0 78.9 36.8% 51.9 107.9%
margins 22.9% 19.4% 14.3%
Depreciation 9.8 7.3 8.2
EBIT 98.2 71.6 37.2% 43.8 124.4%
Interest 1.8 3.8 -53.9% 3.3 -47.2%
Other Income 3.6 0.7 417.3% 7.8 -53.8%
Exchange loss/(gain) -3.9 -6.7 -41.4% 0.8 -563.0%
PBT 103.9 75.1 38.3% 47.4 119.4%
Tax 32.2 26.6 21.1% 2.2 1378.9%
Tax rate 31.0% 35.4% 4.6%
EO items 0.0 0.0 0.0
PAT reported 71.7 48.5 47.8% 45.2 58.7%
PAT adjusted 71.7 48.5 47.8% 45.2 58.7%
Equity Capital 13.5 13.5 13.5
FV 1.0 1.0 1.0
Adj EPS 5.3 3.6 47.8% 3.3 58.7%
3 | P a g e
InitiatingCoverage
tiatingCoverage
tingCoverage
gCoverage
Coverage
verage
rage
ge
PI Industries Ltd.
Q1FY15ResultUpdate–30July2014
Financials
P&L (Rs. Cr) FY13A FY14A FY15E FY16E Balance Sheet (Rs Cr) FY13A FY14A FY15E FY16E
Net Sales 1151.4 1595.5 1963.8 2414.3 Share Capital 13.5 13.6 13.6 13.6
% change 31.0% 38.6% 23.1% 22.9% Reserves & Surplus 518.2 680.9 887.3 1154.0
EBITDA 180.9 289.0 379.0 475.6 Net Worth 531.7 694.5 900.9 1167.6
EBITDA margin (%) 15.7% 18.1% 19.3% 19.7% Net Deferred Tax Liab 48.3 43.7 43.7 43.7
Depn & Amort 22.0 31.6 38.7 46.1 Total Loans 217.2 115.9 83.3 73.2
Operating income 158.9 257.4 340.3 429.5 Other LT Liab 12.5 13.8 14.8 15.8
Interest 21.8 11.8 9.2 8.1 Trade Payables 239.6 291.6 333.7 391.0
Other Income 8.2 15.8 16.0 18.0 Provisions 22.4 32.4 34.4 37.4
PBT 145.0 261.4 347.1 439.4 Other CL 63.0 126.1 170.0 200.0
Tax 47.7 73.3 100.7 123.0 Total Liabilities 1134.7 1317.9 1580.8 1928.7
EO* 0.0 0.0 0.0 0.0 Net Fixed Assets 478.1 534.2 650.4 769.3
Reported PAT 97.3 188.1 246.5 316.4 Capital WIP 60.5 35.0 30.0 15.0
Adj PAT 97.3 188.1 246.5 316.4 Investments 0.5 0.5 0.5 0.5
Sh o/s - Diluted 13.6 13.6 13.6 13.6 Cash & Bank 16.1 43.8 53.8 107.5
Adj EPS 7.2 13.8 18.1 23.2 Inventories 241.7 318.8 367.9 450.7
EPS growth (%) -6.0% 93.2% 31.0% 28.4% Debtors 262.5 256.8 327.3 402.4
Cash EPS 8.8 16.1 21.0 26.6 Other CA 75.2 128.9 150.9 183.3
Quarterly - Standalone Sep-13 Dec-13 Mar-14 Jun-14 Total Assets 1134.7 1317.9 1580.8 1928.7
Net Sales 462.8 363.4 362.7 471.2 Cash Flow (Rs. Cr) FY13A FY14A FY15E FY16E
EBITDA 92.1 62.7 51.9 108.0 Op CF before tax & WC 180.6 289.0 379.0 475.6
Dep & Amorz 8.0 7.9 8.2 9.8 Change in WC -9.9 -3.3 -52.5 -99.1
Operating Income 84.1 54.8 43.8 98.2 Tax -47.7 -73.3 -100.7 -123.0
Interest 2.7 2.0 3.3 1.8 CF from Operation 123.0 212.4 225.8 253.5
Other Inc. 3.1 4.0 7.8 3.6 Capex -181.3 -62.1 -150.0 -150.0
PBT 82.0 53.5 47.4 103.9 Inv & Oth Income 8.2 15.8 16.0 18.0
Tax 26.7 18.8 2.2 32.2 CF from Investing -173.1 -46.3 -134.0 -132.0
EO (less)/Add 0.0 0.0 0.0 0.0 Diviend Paid -15.8 -31.9 -40.1 -49.6
Reported PAT 55.3 34.7 45.2 71.7 Sh Capital & Premium 118.6 0.0 0.0 0.0
EPS (Rs.) 4.1 2.6 3.3 5.3 Interest Paid -21.8 -11.8 -9.2 -8.1
Ratios FY13A FY14A FY15E FY16E Loans -29.6 -101.3 -32.6 -10.1
EBITDA margin (%) 15.7% 18.1% 19.3% 19.7% Interest Paid & Others -16.5 -5.2 -9.1 -8.1
Adj PAT margin (%) 8.5% 11.8% 12.6% 13.1% CF from Financing 56.8 -138.4 -81.8 -67.8
PAT Growth (%) -6.0% 93.2% 31.0% 28.4% Net Chg. in Cash 6.7 27.6 10.0 53.7
Price Earnings (x) 56.8 29.4 22.4 17.5 Cash at beginning 9.4 16.1 43.8 53.8
ROE (%) 22.7% 30.7% 30.9% 30.6% Cash at end 16.1 43.8 53.8 107.5
ROCE (%) 24.1% 33.0% 37.9% 38.6% Per Share Data FY13A FY14A FY15E FY16E
Debt/Equity Ratio (x) 0.5 0.3 0.0 0.0 Adj EPS 7.2 13.8 18.1 23.2
Price/BV (x) 10.4 8.0 6.1 4.7 BV per share 39.1 51.0 66.2 85.8
EV / Sales 4.9 3.5 2.8 2.3 Cash per share 1.2 3.2 4.0 7.9
EV / EBITDA 31.5 19.3 14.7 11.5 Dividend per share 1.0 2.0 2.5 3.1
4 | P a g e
InitiatingCoverage
tiatingCoverage
tingCoverage
gCoverage
Coverage
verage
rage
ge
PI Industries Ltd.
Q1FY15ResultUpdate–30July2014
Disclaimer:
This Document has been prepared by Nirmal Bang Research (A Division of Nirmal Bang Securities PVT LTD). The information, analysis and
estimates contained herein are based on Nirmal Bang Research assessment and have been obtained from sources believed to be reliable. This
document is meant for the use of the intended recipient only. This document, at best, represents Nirmal Bang Research opinion and is meant for
general information only. Nirmal Bang Research, its directors, officers or employees shall not in anyway be responsible for the contents stated
herein. Nirmal Bang Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This
document is not to be considered as an offer to sell or a solicitation to buy any securities. Nirmal Bang Research, its affiliates and their employees
may from time to time hold positions in securities referred to herein. Nirmal Bang Research or its affiliates may from time to time solicit from or
perform investment banking or other services for any company mentioned in this document.
Nirmal Bang Research (Division of Nirmal Bang Securities Pvt Ltd)
B-2, 301/302, Marathon Innova,
Opp. Peninsula Corporate Park
Off. Ganpatrao Kadam Marg
Lower Parel (W), Mumbai-400013
Board No : 91 22 3926 8000/8001
Fax : 022 3926 8010

More Related Content

What's hot

EISEC - Grauer and weil (India) Ltd_Q2FY15
EISEC - Grauer and weil (India) Ltd_Q2FY15EISEC - Grauer and weil (India) Ltd_Q2FY15
EISEC - Grauer and weil (India) Ltd_Q2FY15
Pushkaraj Jamsandekar
 
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
IndiaNotes.com
 
EISEC - Grauer and Weil (India) Ltd - IC
EISEC - Grauer and Weil (India) Ltd - ICEISEC - Grauer and Weil (India) Ltd - IC
EISEC - Grauer and Weil (India) Ltd - IC
Pushkaraj Jamsandekar
 
Colgate ru2 qfy2011-281010
Colgate  ru2 qfy2011-281010Colgate  ru2 qfy2011-281010
Colgate ru2 qfy2011-281010
Angel Broking
 
Hero honda ru2 qfy2011-291010
Hero honda ru2 qfy2011-291010Hero honda ru2 qfy2011-291010
Hero honda ru2 qfy2011-291010
Angel Broking
 

What's hot (19)

EISEC - Grauer and weil (India) Ltd_Q2FY15
EISEC - Grauer and weil (India) Ltd_Q2FY15EISEC - Grauer and weil (India) Ltd_Q2FY15
EISEC - Grauer and weil (India) Ltd_Q2FY15
 
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
 
EISEC - Grauer and Weil (India) Ltd - IC
EISEC - Grauer and Weil (India) Ltd - ICEISEC - Grauer and Weil (India) Ltd - IC
EISEC - Grauer and Weil (India) Ltd - IC
 
Ceat Q1FY15: Higher opex impact margins; Book profits
 Ceat Q1FY15: Higher opex impact margins; Book profits Ceat Q1FY15: Higher opex impact margins; Book profits
Ceat Q1FY15: Higher opex impact margins; Book profits
 
Financia managment project slides
Financia managment project slidesFinancia managment project slides
Financia managment project slides
 
Presentation on Adamjee Insurance
Presentation on Adamjee Insurance Presentation on Adamjee Insurance
Presentation on Adamjee Insurance
 
Lumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyLumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buy
 
Harman q3 fy2014_slide_deck
Harman q3 fy2014_slide_deckHarman q3 fy2014_slide_deck
Harman q3 fy2014_slide_deck
 
Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019
 
IFM - optionality
IFM - optionality IFM - optionality
IFM - optionality
 
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 TVS Motor Q1FY15: Business outlook strong; New launch impacts margins TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 
Colgate ru2 qfy2011-281010
Colgate  ru2 qfy2011-281010Colgate  ru2 qfy2011-281010
Colgate ru2 qfy2011-281010
 
Bajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continueBajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continue
 
Venus Remedies Research Report Update
Venus Remedies Research Report UpdateVenus Remedies Research Report Update
Venus Remedies Research Report Update
 
HGSL 1QFY18
HGSL 1QFY18HGSL 1QFY18
HGSL 1QFY18
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
SEPLAT
SEPLATSEPLAT
SEPLAT
 
Hero honda ru2 qfy2011-291010
Hero honda ru2 qfy2011-291010Hero honda ru2 qfy2011-291010
Hero honda ru2 qfy2011-291010
 
KPIT 1QFY18
KPIT 1QFY18KPIT 1QFY18
KPIT 1QFY18
 

Similar to PI Industries: Another strong performance; Sales up 16% in Q1FY15

Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
IndiaNotes.com
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
IndiaNotes.com
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014
IndiaNotes.com
 
2q15quarterlyresultsdeck 150730180803-lva1-app6892
2q15quarterlyresultsdeck 150730180803-lva1-app68922q15quarterlyresultsdeck 150730180803-lva1-app6892
2q15quarterlyresultsdeck 150730180803-lva1-app6892
Jean Edouard Benois
 

Similar to PI Industries: Another strong performance; Sales up 16% in Q1FY15 (20)

Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
 
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
 Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
 
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
Pidilite Ind: Reports 11% volume growth in a tough operating environment - Pr...
 
Aksigorta - June 2015 - Conference Call Presentation
Aksigorta - June 2015 - Conference Call PresentationAksigorta - June 2015 - Conference Call Presentation
Aksigorta - June 2015 - Conference Call Presentation
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
 
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 Zensar Technologies Q1FY15: Results in line with our expectations, buy Zensar Technologies Q1FY15: Results in line with our expectations, buy
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
 
Aksigorta cc presentation_2016_june_v4
Aksigorta cc presentation_2016_june_v4Aksigorta cc presentation_2016_june_v4
Aksigorta cc presentation_2016_june_v4
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
Persistent 1QFY18
Persistent 1QFY18Persistent 1QFY18
Persistent 1QFY18
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18
 
Aksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call PresentationAksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call Presentation
 
Q2 results overview 2014
Q2 results overview 2014Q2 results overview 2014
Q2 results overview 2014
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
 
Dhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; BuyDhanuka Agritech's FY15 net profit up 14%; Buy
Dhanuka Agritech's FY15 net profit up 14%; Buy
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014
 
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
Entertainment Network Ltd: Stock Price & Q4 Results Of Entertainment Network ...
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
 
LinkedIn Q2 2015 Earnings Call
LinkedIn Q2 2015 Earnings CallLinkedIn Q2 2015 Earnings Call
LinkedIn Q2 2015 Earnings Call
 
2q15quarterlyresultsdeck 150730180803-lva1-app6892
2q15quarterlyresultsdeck 150730180803-lva1-app68922q15quarterlyresultsdeck 150730180803-lva1-app6892
2q15quarterlyresultsdeck 150730180803-lva1-app6892
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 

Recently uploaded

VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
priyasharma62062
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
amitlee9823
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
dipikadinghjn ( Why You Choose Us? ) Escorts
 

Recently uploaded (20)

7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunities
 
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
(INDIRA) Call Girl Mumbai Call Now 8250077686 Mumbai Escorts 24x7
 
VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
VIP Independent Call Girls in Mumbai 🌹 9920725232 ( Call Me ) Mumbai Escorts ...
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
 
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
CBD Belapur Expensive Housewife Call Girls Number-📞📞9833754194 No 1 Vipp HIgh...
 
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
VIP Call Girl in Mumbai 💧 9920725232 ( Call Me ) Get A New Crush Everyday Wit...
 
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
Kharghar Blowjob Housewife Call Girls NUmber-9833754194-CBD Belapur Internati...
 
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
VIP Independent Call Girls in Mira Bhayandar 🌹 9920725232 ( Call Me ) Mumbai ...
 
(INDIRA) Call Girl Srinagar Call Now 8617697112 Srinagar Escorts 24x7
(INDIRA) Call Girl Srinagar Call Now 8617697112 Srinagar Escorts 24x7(INDIRA) Call Girl Srinagar Call Now 8617697112 Srinagar Escorts 24x7
(INDIRA) Call Girl Srinagar Call Now 8617697112 Srinagar Escorts 24x7
 
Top Rated Pune Call Girls Dighi ⟟ 6297143586 ⟟ Call Me For Genuine Sex Servi...
Top Rated  Pune Call Girls Dighi ⟟ 6297143586 ⟟ Call Me For Genuine Sex Servi...Top Rated  Pune Call Girls Dighi ⟟ 6297143586 ⟟ Call Me For Genuine Sex Servi...
Top Rated Pune Call Girls Dighi ⟟ 6297143586 ⟟ Call Me For Genuine Sex Servi...
 
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
Vasai-Virar High Profile Model Call Girls📞9833754194-Nalasopara Satisfy Call ...
 
Call Girls in New Friends Colony Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escort...
Call Girls in New Friends Colony Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escort...Call Girls in New Friends Colony Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escort...
Call Girls in New Friends Colony Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escort...
 
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbaiVasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
Vasai-Virar Fantastic Call Girls-9833754194-Call Girls MUmbai
 
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
Mira Road Memorable Call Grls Number-9833754194-Bhayandar Speciallty Call Gir...
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech Belgium
 
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
Call Girls Banaswadi Just Call 👗 7737669865 👗 Top Class Call Girl Service Ban...
 
Kopar Khairane Russian Call Girls Number-9833754194-Navi Mumbai Fantastic Unl...
Kopar Khairane Russian Call Girls Number-9833754194-Navi Mumbai Fantastic Unl...Kopar Khairane Russian Call Girls Number-9833754194-Navi Mumbai Fantastic Unl...
Kopar Khairane Russian Call Girls Number-9833754194-Navi Mumbai Fantastic Unl...
 
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
VIP Independent Call Girls in Bandra West 🌹 9920725232 ( Call Me ) Mumbai Esc...
 
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
VIP Call Girl in Mumbai Central 💧 9920725232 ( Call Me ) Get A New Crush Ever...
 

PI Industries: Another strong performance; Sales up 16% in Q1FY15

  • 1. 1 | P a g e InitiatingCoverage tiatingCoverage tingCoverage gCoverage Coverage verage rage ge PI Industries Ltd. Q1FY15ResultUpdate–30July2014 4 Recommendation HOLD Another strong performance… PI Industries posted strong quarter with 16% growth in sales for the quarter. However, key highlight of the quarter is improvement in margins which has moved up by ~348 up yoy and ~859 bps qoq (Q1 is seasonally strong quarter in terms of margins) to 22.9%. The company is expected to end FY15 with sales growth of 20% with 100-200 bps improvement in margins (as against the earlier guidance of 25% growth and stable margins). Key Highlights  CSM: Key highlight of the quarter was increase in order book to $435mn from $395 mn in Q4FY14 despite clocking revenues of Rs 225 cr (up 8% yoy). Q3 and Q4 quarters are expected to high growth quarters as the company is expecting few products to get commercialized in addition with higher volumes from existing products. Top 5 products contribute 45% of revenues and Top 5 customers’ accounts for 50-60% of revenues. Jambusar plant is working at its full capacity hence the company is undergoing Phase II expansion and putting up two new lines at the site which are expected to be operational by Q2FY16 with capex of Rs 300 cr spread over FY15-16. Management has guided for 20% growth for FY15.  Agri: PI industries’ Agri segment has reported healthy sales growth of 24.5% at Rs 246cr for the quarter. The performance is backed equally by both volume growth (12-13%) and mix of price and product mix (12-13%). One in-licensed insecticide to be launched in Q2FY15 and one more product in Rabi season. despite posting good growth in Q1, the company has lowered its guidance to 20% as a cautious move owning to current monsoon season. Valuation & Recommendation We believe that healthy order book of CSM, strong balance sheet and new product launches in Agri Input segment will drive near to medium term growth. On the other hand CSM segment gaining traction with higher margins is acting as a de-risk model to domestic business. In addition, macro factors like low per- capita pesticides consumption in the country, increasing MSPs and increasing acceptance for the need of crop protection products make PI Industries a good long term bet. We continue to maintain our positive stance on the stock. We recommend to HOLD the stock for the price target of Rs 465 (20x on FY16E EPS) CMP (28/07/14) Rs 406 Target Price Rs 465 Sector Agrochemicals Stock Details BSE Code 523642 NSE Code PIIND Bloomberg Code PI IN Market Cap (Rs cr) 5,526 Free Float (%) 41.4 52- wk HI/Lo (Rs) 434/120 Avg. volume BSE (Quarterly) 26,076 Face Value (Rs) Re. 1 Dividend (FY 14) 200% Shares o/s (Cr) 13.55 Relative Performance 1Mth 3Mth 1Yr PI Ind. 21.7% 65.6% 208.8% Sensex 2.7% 14.6% 31.6% Shareholding Pattern 30 th June 14 Promoters Holding 58.57 Institutional (Incl. FII) 25.11 Corporate Bodies 2.44 Public & others 13.88 Runjhun Jain 022 3926 8177 Senior Research Analyst runjhun.jain@nirmalbang.com Year Consolidated Sales (Rs cr) Growth (%) EBITDA (Rs cr) Margin (%) Rep. PAT (Rs cr) Margin (%) EPS (Rs) P/E (x) ROE (%) FY13A 1151.4 31.0% 180.9 15.7% 97.3 8.5% 7.2 56.8 22.7% FY14A 1595.5 38.6% 289.0 18.1% 188.1 11.8% 13.8 29.4 30.7% FY15E 1963.8 23.1% 379.0 19.3% 246.5 12.6% 18.1 22.4 30.9% FY16E 2414.3 22.9% 475.6 19.7% 316.4 13.1% 23.2 17.5 30.6% 0 100 200 300 400 500 25-Jul 25-Oct 25-Jan 25-Apr 25-Jul
  • 2. 2 | P a g e InitiatingCoverage tiatingCoverage tingCoverage gCoverage Coverage verage rage ge PI Industries Ltd. Q1FY15ResultUpdate–30July2014 Quarterly Result Table (Standalone) Particulars (Rs Cr) Q1FY15 Q1FY14 yoy Q4FY14 qoq Net Sales 471.2 406.1 16.0% 362.7 29.9% Cost of materials 247.3 221.8 11.5% 191.9 28.9% Purchase of goods 20.8 18.2 14.4% 5.8 259.7% Employees Cost 31.7 27.4 15.8% 31.8 -0.4% Other Exps 63.5 59.8 6.1% 81.3 -21.9% EBITDA 108.0 78.9 36.8% 51.9 107.9% margins 22.9% 19.4% 14.3% Depreciation 9.8 7.3 8.2 EBIT 98.2 71.6 37.2% 43.8 124.4% Interest 1.8 3.8 -53.9% 3.3 -47.2% Other Income 3.6 0.7 417.3% 7.8 -53.8% Exchange loss/(gain) -3.9 -6.7 -41.4% 0.8 -563.0% PBT 103.9 75.1 38.3% 47.4 119.4% Tax 32.2 26.6 21.1% 2.2 1378.9% Tax rate 31.0% 35.4% 4.6% EO items 0.0 0.0 0.0 PAT reported 71.7 48.5 47.8% 45.2 58.7% PAT adjusted 71.7 48.5 47.8% 45.2 58.7% Equity Capital 13.5 13.5 13.5 FV 1.0 1.0 1.0 Adj EPS 5.3 3.6 47.8% 3.3 58.7%
  • 3. 3 | P a g e InitiatingCoverage tiatingCoverage tingCoverage gCoverage Coverage verage rage ge PI Industries Ltd. Q1FY15ResultUpdate–30July2014 Financials P&L (Rs. Cr) FY13A FY14A FY15E FY16E Balance Sheet (Rs Cr) FY13A FY14A FY15E FY16E Net Sales 1151.4 1595.5 1963.8 2414.3 Share Capital 13.5 13.6 13.6 13.6 % change 31.0% 38.6% 23.1% 22.9% Reserves & Surplus 518.2 680.9 887.3 1154.0 EBITDA 180.9 289.0 379.0 475.6 Net Worth 531.7 694.5 900.9 1167.6 EBITDA margin (%) 15.7% 18.1% 19.3% 19.7% Net Deferred Tax Liab 48.3 43.7 43.7 43.7 Depn & Amort 22.0 31.6 38.7 46.1 Total Loans 217.2 115.9 83.3 73.2 Operating income 158.9 257.4 340.3 429.5 Other LT Liab 12.5 13.8 14.8 15.8 Interest 21.8 11.8 9.2 8.1 Trade Payables 239.6 291.6 333.7 391.0 Other Income 8.2 15.8 16.0 18.0 Provisions 22.4 32.4 34.4 37.4 PBT 145.0 261.4 347.1 439.4 Other CL 63.0 126.1 170.0 200.0 Tax 47.7 73.3 100.7 123.0 Total Liabilities 1134.7 1317.9 1580.8 1928.7 EO* 0.0 0.0 0.0 0.0 Net Fixed Assets 478.1 534.2 650.4 769.3 Reported PAT 97.3 188.1 246.5 316.4 Capital WIP 60.5 35.0 30.0 15.0 Adj PAT 97.3 188.1 246.5 316.4 Investments 0.5 0.5 0.5 0.5 Sh o/s - Diluted 13.6 13.6 13.6 13.6 Cash & Bank 16.1 43.8 53.8 107.5 Adj EPS 7.2 13.8 18.1 23.2 Inventories 241.7 318.8 367.9 450.7 EPS growth (%) -6.0% 93.2% 31.0% 28.4% Debtors 262.5 256.8 327.3 402.4 Cash EPS 8.8 16.1 21.0 26.6 Other CA 75.2 128.9 150.9 183.3 Quarterly - Standalone Sep-13 Dec-13 Mar-14 Jun-14 Total Assets 1134.7 1317.9 1580.8 1928.7 Net Sales 462.8 363.4 362.7 471.2 Cash Flow (Rs. Cr) FY13A FY14A FY15E FY16E EBITDA 92.1 62.7 51.9 108.0 Op CF before tax & WC 180.6 289.0 379.0 475.6 Dep & Amorz 8.0 7.9 8.2 9.8 Change in WC -9.9 -3.3 -52.5 -99.1 Operating Income 84.1 54.8 43.8 98.2 Tax -47.7 -73.3 -100.7 -123.0 Interest 2.7 2.0 3.3 1.8 CF from Operation 123.0 212.4 225.8 253.5 Other Inc. 3.1 4.0 7.8 3.6 Capex -181.3 -62.1 -150.0 -150.0 PBT 82.0 53.5 47.4 103.9 Inv & Oth Income 8.2 15.8 16.0 18.0 Tax 26.7 18.8 2.2 32.2 CF from Investing -173.1 -46.3 -134.0 -132.0 EO (less)/Add 0.0 0.0 0.0 0.0 Diviend Paid -15.8 -31.9 -40.1 -49.6 Reported PAT 55.3 34.7 45.2 71.7 Sh Capital & Premium 118.6 0.0 0.0 0.0 EPS (Rs.) 4.1 2.6 3.3 5.3 Interest Paid -21.8 -11.8 -9.2 -8.1 Ratios FY13A FY14A FY15E FY16E Loans -29.6 -101.3 -32.6 -10.1 EBITDA margin (%) 15.7% 18.1% 19.3% 19.7% Interest Paid & Others -16.5 -5.2 -9.1 -8.1 Adj PAT margin (%) 8.5% 11.8% 12.6% 13.1% CF from Financing 56.8 -138.4 -81.8 -67.8 PAT Growth (%) -6.0% 93.2% 31.0% 28.4% Net Chg. in Cash 6.7 27.6 10.0 53.7 Price Earnings (x) 56.8 29.4 22.4 17.5 Cash at beginning 9.4 16.1 43.8 53.8 ROE (%) 22.7% 30.7% 30.9% 30.6% Cash at end 16.1 43.8 53.8 107.5 ROCE (%) 24.1% 33.0% 37.9% 38.6% Per Share Data FY13A FY14A FY15E FY16E Debt/Equity Ratio (x) 0.5 0.3 0.0 0.0 Adj EPS 7.2 13.8 18.1 23.2 Price/BV (x) 10.4 8.0 6.1 4.7 BV per share 39.1 51.0 66.2 85.8 EV / Sales 4.9 3.5 2.8 2.3 Cash per share 1.2 3.2 4.0 7.9 EV / EBITDA 31.5 19.3 14.7 11.5 Dividend per share 1.0 2.0 2.5 3.1
  • 4. 4 | P a g e InitiatingCoverage tiatingCoverage tingCoverage gCoverage Coverage verage rage ge PI Industries Ltd. Q1FY15ResultUpdate–30July2014 Disclaimer: This Document has been prepared by Nirmal Bang Research (A Division of Nirmal Bang Securities PVT LTD). The information, analysis and estimates contained herein are based on Nirmal Bang Research assessment and have been obtained from sources believed to be reliable. This document is meant for the use of the intended recipient only. This document, at best, represents Nirmal Bang Research opinion and is meant for general information only. Nirmal Bang Research, its directors, officers or employees shall not in anyway be responsible for the contents stated herein. Nirmal Bang Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This document is not to be considered as an offer to sell or a solicitation to buy any securities. Nirmal Bang Research, its affiliates and their employees may from time to time hold positions in securities referred to herein. Nirmal Bang Research or its affiliates may from time to time solicit from or perform investment banking or other services for any company mentioned in this document. Nirmal Bang Research (Division of Nirmal Bang Securities Pvt Ltd) B-2, 301/302, Marathon Innova, Opp. Peninsula Corporate Park Off. Ganpatrao Kadam Marg Lower Parel (W), Mumbai-400013 Board No : 91 22 3926 8000/8001 Fax : 022 3926 8010